SCHEMBL5112339

SCHEMBL5112339

CC[C@@H](CO)NC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1437055 1.00 — —
SCHEMBL5197140 1.00 — —
SCHEMBL4233769 0.87 — —
SCHEMBL6939465 0.86 LMNA (0.38) —
Hydrochloric Acid SCHEMBL10822892 0.84 CA12 (0.50) —
SCHEMBL2840047 0.84 — —
SCHEMBL4284738 0.81 CA2 (0.39) —
SCHEMBL4284741 0.81 CNR1 (0.41) —
SCHEMBL5943150 0.81 CERT1 (0.36) —
SCHEMBL48989 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240199588-A1 Chiral TACN/NOTA compounds/derivatives with and without metals for application THE HONG KONG POLYTECHNIC UNIVERSITY (CN) 2024-06-20 — — US disclosed
US-20230219975-A1 PYRIDO[2,3-B][1,4]OXAZINES OR TETRAHYDROPYRIDO[2,3-B][1,4]OXAZEPINES AS IAP ANTAGONISTS BEONE MEDICINES I GMBH (CH) 2023-07-13 — — US disclosed
EP-3317277-B1 SOMATOSTATIN MODULATORS AND USES THEREOF CRINETICS PHARMACEUTICALS INC (US) 2021-01-20 — — EP disclosed
US-9957267-B2 Somatostatin modulators and uses thereof Crinetics Pharmaceuticals, Inc. (US) 2018-05-01 — — US disclosed
US-20170002001-A1 SOMATOSTATIN MODULATORS AND USES THEREOF Crinetics Pharmaceuticals, Inc. 2017-01-05 — — US disclosed
US-20150166523-A1 BRANCHED CHAIN ALKYL HETEROAROMATIC RING DERIVATIVE TAISHO PHARMACEUTICAL CO., LTD. (JP) 2015-06-18 — — US disclosed
EP-2862855-A1 BRANCHED CHAIN ALKYL HETEROAROMATIC RING DERIVATIVE Taisho Pharmaceutical Co., Ltd. (JP) 2015-04-22 — — EP disclosed
US-8420694-B2 Pyrrolidin-2-one derivatives as androgen receptor modulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-04-16 — — US disclosed
EP-2176220-B1 Pyrrolidin-2-one derivatives as androgen receptor modulators TAKEDA PHARMACEUTICAL (JP) 2013-03-27 — — EP disclosed
US-7365075-B2 Aryl sulfonamide compounds and uses related thereto AMGEN INC. (US) 2008-04-29 — — US disclosed
US-20050277649-A1 Aryl sulfonamide compounds and uses related thereto AMGEN SF, LLC (US) 2005-12-15 — — US disclosed
Send feedback